Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZVRA
#2644
Zevra Therapeutics, Inc. - Common Stock
12.9
6
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.77%
Monthly Change
+1.49%
6 month change
+46.94%
Year Change
+21.80%
Previous Close
13.0
6
Open
12.9
6
Low
12.9
6
High
12.9
6
Volume
60
Markets
US Stock Market
Healthcare
Biotechnology
ZVRA
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
54.68 M
56.14 M
56.3 M
58.71 M
59.12 M
59.12 M
Valuation ratios
Enterprise value
432.3 M
507.53 M
542.26 M
525.58 M
455.36 M
791.72 M
Price to earnings ratio
16.14
7.36
22.12
6.64
4.64
7.47
Price to sales ratio
27.72
14.08
9.51
4.82
4.39
7.07
Price to cash flow ratio
6.52
11.65
36.61
-321.07
42.65
68.69
Price to book ratio
2.62
2.11
1.93
3.32
0.88
1.42
Enterprise value to EBITDA ratio
-8.56
-16.88
-254.11
26.06
14.08
24.49
Profitability ratios
Return on assets %
-0.02
0.29
-0
0.04
0.14
0.14
Return on equity %
-0.08
0.64
-0
0.08
0.18
0.18
Return on invested capital %
-8.18
-642.98
17.92
47.89
203.51
203.51
Gross margin %
85.49
52.17
95.25
95.55
94.76
94.76
Operating margin %
-26.28
-274.48
15.9
27.3
143.97
143.97
EBITDA margin %
-3.69
12.82
23.36
33.74
31.51
31.51
Net margin %
-15.19
288.66
-2.09
35.65
104.61
104.61
Liquidity ratios
Quick ratio
2.93
7.81
8.57
5.63
4.84
4.84
Current ratio
3.02
7.85
8.62
5.68
4.89
4.89
Inventory turnover
1.31
11.17
1
0.98
0.94
0.94
Asset turnover
0.12
0.1
0.1
0.12
0.13
0.13
Solvency ratios
Debt to assets ratio
0.35
0.24
0.23
0.22
0
0
Debt to equity ratio
1.46
0.52
0.46
0.4
0
0
Long term debt to total assets ratio
0.35
0.24
0.23
0.22
0.22
0.22
Long term debt to total equity ratio
1.46
0.52
0.46
0.4
0.3
0.3
Per share metrics
Operating cash flow per share
0.07
-0.06
0.08
0.1
0.1
0.22
EBIT per share
0.02
0.03
0.1
0.19
0.18
0.51
EBITDA per share
0.01
0.06
0.11
0.2
0.19
0.56
Total debt per share
-0.54
1.08
1.1
1.08
0
0
Cash per share
-0.56
3.6
3.57
3.34
3.33
3.33
Net current asset value per share
-0.73
4.02
4.02
3.89
3.82
3.82
Tangible book value per share
0.28
2.08
2.38
2.7
3.42
3.42
Working capital per share
-0.49
3.51
3.56
3.21
3.04
3.04
Book value per share
-0.37
2.08
2.38
2.7
3.42
3.42
News
Zevra Therapeutics, Inc. (ZVRA) Q1 2026 Earnings Call Transcript
Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass Estimates
Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates
BTIG initiates Zevra Therapeutics stock with buy on Miplyffa outlook
Micron and BioNTech among market cap stock movers on Tuesday
Micron and Palantir among market cap stock movers on Tuesday
ExxonMobil, Chevron edge lower premarket; Hewlett Packard Enterprise climbs
Guggenheim raises Zevra Therapeutics stock price target to $23
Earnings call transcript: Zevra Therapeutics Q4 2025 earnings beat forecasts
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript
Zevra Therapeutics earnings beat by $0.14, revenue topped estimates
Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates